0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Biopharmaceutical Cold Chain Transport - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-16K5877
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Biopharmaceutical Cold Chain Transport Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Biopharmaceutical Cold Chain Transport - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-16K5877
Report
October 2024
Pages:131
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Biopharmaceutical Cold Chain Transport - Market Size

The global market for Biopharmaceutical Cold Chain Transport was estimated to be worth US$ 13130 million in 2023 and is forecast to a readjusted size of US$ 20090 million by 2030 with a CAGR of 6.3% during the forecast period 2024-2030

Biopharmaceutical Cold Chain Transport - Market

Biopharmaceutical Cold Chain Transport - Market

Biopharmaceutical Logistics is the logistics of Biopharmaceutical, medical and surgical supplies, and other products needed to support doctors, nurses, and other health and dental care providers.
The Biopharmaceutical Transport market is primarily driven by the rapid growth of the biopharmaceutical industry, which includes the production and distribution of biologic drugs, vaccines, and other complex biopharmaceutical products. These products often require specialized transportation and handling due to their sensitivity to temperature variations and the need for maintaining product integrity. The increasing demand for personalized medicine, cell therapies, and advanced treatments further fuels the need for reliable and efficient biopharmaceutical transport solutions. However, this market also faces challenges such as stringent regulatory requirements, complex logistics networks, and the need to maintain a consistent cold chain to ensure the stability and efficacy of biopharmaceutical products during transit. Innovations in temperature-controlled packaging, monitoring technologies, and streamlined logistics processes are crucial to addressing these challenges and ensuring the safe and timely delivery of biopharmaceuticals to patients worldwide.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical Cold Chain Transport, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Biopharmaceutical Cold Chain Transport by region & country, by Type, and by Application.
The Biopharmaceutical Cold Chain Transport market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical Cold Chain Transport.
Market Segmentation

Scope of Biopharmaceutical Cold Chain Transport - Market Report

Report Metric Details
Report Name Biopharmaceutical Cold Chain Transport - Market
Forecasted market size in 2030 US$ 20090 million
CAGR 6.3%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
  • Blood Products
  • Vaccines
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Deutsche Post DHL, Kuehne + Nagel, FedEx, AmerisourceBergen, UPS (Marken), DB Schenker, XPO Logistics, Panalpina, Nippon Express, GEODIS, VersaCold, Agility, DSV, Sinotrans, Kerry Logistics, SF Express, CEVA, CH Robinson, Air Canada Cargo
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Biopharmaceutical Cold Chain Transport manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Biopharmaceutical Cold Chain Transport in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Biopharmaceutical Cold Chain Transport in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Biopharmaceutical Cold Chain Transport - Market size in 2030?

Ans: The Biopharmaceutical Cold Chain Transport - Market size in 2030 will be US$ 20090 million.

Who are the main players in the Biopharmaceutical Cold Chain Transport - Market report?

Ans: The main players in the Biopharmaceutical Cold Chain Transport - Market are Deutsche Post DHL, Kuehne + Nagel, FedEx, AmerisourceBergen, UPS (Marken), DB Schenker, XPO Logistics, Panalpina, Nippon Express, GEODIS, VersaCold, Agility, DSV, Sinotrans, Kerry Logistics, SF Express, CEVA, CH Robinson, Air Canada Cargo

What are the Application segmentation covered in the Biopharmaceutical Cold Chain Transport - Market report?

Ans: The Applications covered in the Biopharmaceutical Cold Chain Transport - Market report are Blood Products, Vaccines, Others

What are the Type segmentation covered in the Biopharmaceutical Cold Chain Transport - Market report?

Ans: The Types covered in the Biopharmaceutical Cold Chain Transport - Market report are Ground Shipping, Sea Shipping, Air Shipping

Recommended Reports

Cold Chain Logistics

Biopharma Packaging

Vaccine & Medicine Transport

1 Market Overview
1.1 Biopharmaceutical Cold Chain Transport Product Introduction
1.2 Global Biopharmaceutical Cold Chain Transport Market Size Forecast
1.3 Biopharmaceutical Cold Chain Transport Market Trends & Drivers
1.3.1 Biopharmaceutical Cold Chain Transport Industry Trends
1.3.2 Biopharmaceutical Cold Chain Transport Market Drivers & Opportunity
1.3.3 Biopharmaceutical Cold Chain Transport Market Challenges
1.3.4 Biopharmaceutical Cold Chain Transport Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Biopharmaceutical Cold Chain Transport Players Revenue Ranking (2023)
2.2 Global Biopharmaceutical Cold Chain Transport Revenue by Company (2019-2024)
2.3 Key Companies Biopharmaceutical Cold Chain Transport Manufacturing Base Distribution and Headquarters
2.4 Key Companies Biopharmaceutical Cold Chain Transport Product Offered
2.5 Key Companies Time to Begin Mass Production of Biopharmaceutical Cold Chain Transport
2.6 Biopharmaceutical Cold Chain Transport Market Competitive Analysis
2.6.1 Biopharmaceutical Cold Chain Transport Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Biopharmaceutical Cold Chain Transport Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical Cold Chain Transport as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Ground Shipping
3.1.2 Sea Shipping
3.1.3 Air Shipping
3.2 Global Biopharmaceutical Cold Chain Transport Sales Value by Type
3.2.1 Global Biopharmaceutical Cold Chain Transport Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Biopharmaceutical Cold Chain Transport Sales Value, by Type (2019-2030)
3.2.3 Global Biopharmaceutical Cold Chain Transport Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Blood Products
4.1.2 Vaccines
4.1.3 Others
4.2 Global Biopharmaceutical Cold Chain Transport Sales Value by Application
4.2.1 Global Biopharmaceutical Cold Chain Transport Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Biopharmaceutical Cold Chain Transport Sales Value, by Application (2019-2030)
4.2.3 Global Biopharmaceutical Cold Chain Transport Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Biopharmaceutical Cold Chain Transport Sales Value by Region
5.1.1 Global Biopharmaceutical Cold Chain Transport Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Biopharmaceutical Cold Chain Transport Sales Value by Region (2019-2024)
5.1.3 Global Biopharmaceutical Cold Chain Transport Sales Value by Region (2025-2030)
5.1.4 Global Biopharmaceutical Cold Chain Transport Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Biopharmaceutical Cold Chain Transport Sales Value, 2019-2030
5.2.2 North America Biopharmaceutical Cold Chain Transport Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Biopharmaceutical Cold Chain Transport Sales Value, 2019-2030
5.3.2 Europe Biopharmaceutical Cold Chain Transport Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Biopharmaceutical Cold Chain Transport Sales Value, 2019-2030
5.4.2 Asia Pacific Biopharmaceutical Cold Chain Transport Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Biopharmaceutical Cold Chain Transport Sales Value, 2019-2030
5.5.2 South America Biopharmaceutical Cold Chain Transport Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Biopharmaceutical Cold Chain Transport Sales Value, 2019-2030
5.6.2 Middle East & Africa Biopharmaceutical Cold Chain Transport Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Biopharmaceutical Cold Chain Transport Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Biopharmaceutical Cold Chain Transport Sales Value
6.3 United States
6.3.1 United States Biopharmaceutical Cold Chain Transport Sales Value, 2019-2030
6.3.2 United States Biopharmaceutical Cold Chain Transport Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Biopharmaceutical Cold Chain Transport Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Biopharmaceutical Cold Chain Transport Sales Value, 2019-2030
6.4.2 Europe Biopharmaceutical Cold Chain Transport Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Biopharmaceutical Cold Chain Transport Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Biopharmaceutical Cold Chain Transport Sales Value, 2019-2030
6.5.2 China Biopharmaceutical Cold Chain Transport Sales Value by Type (%), 2023 VS 2030
6.5.3 China Biopharmaceutical Cold Chain Transport Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Biopharmaceutical Cold Chain Transport Sales Value, 2019-2030
6.6.2 Japan Biopharmaceutical Cold Chain Transport Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Biopharmaceutical Cold Chain Transport Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Biopharmaceutical Cold Chain Transport Sales Value, 2019-2030
6.7.2 South Korea Biopharmaceutical Cold Chain Transport Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Biopharmaceutical Cold Chain Transport Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Biopharmaceutical Cold Chain Transport Sales Value, 2019-2030
6.8.2 Southeast Asia Biopharmaceutical Cold Chain Transport Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Biopharmaceutical Cold Chain Transport Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Biopharmaceutical Cold Chain Transport Sales Value, 2019-2030
6.9.2 India Biopharmaceutical Cold Chain Transport Sales Value by Type (%), 2023 VS 2030
6.9.3 India Biopharmaceutical Cold Chain Transport Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Deutsche Post DHL
7.1.1 Deutsche Post DHL Profile
7.1.2 Deutsche Post DHL Main Business
7.1.3 Deutsche Post DHL Biopharmaceutical Cold Chain Transport Products, Services and Solutions
7.1.4 Deutsche Post DHL Biopharmaceutical Cold Chain Transport Revenue (US$ Million) & (2019-2024)
7.1.5 Deutsche Post DHL Recent Developments
7.2 Kuehne + Nagel
7.2.1 Kuehne + Nagel Profile
7.2.2 Kuehne + Nagel Main Business
7.2.3 Kuehne + Nagel Biopharmaceutical Cold Chain Transport Products, Services and Solutions
7.2.4 Kuehne + Nagel Biopharmaceutical Cold Chain Transport Revenue (US$ Million) & (2019-2024)
7.2.5 Kuehne + Nagel Recent Developments
7.3 FedEx
7.3.1 FedEx Profile
7.3.2 FedEx Main Business
7.3.3 FedEx Biopharmaceutical Cold Chain Transport Products, Services and Solutions
7.3.4 FedEx Biopharmaceutical Cold Chain Transport Revenue (US$ Million) & (2019-2024)
7.3.5 AmerisourceBergen Recent Developments
7.4 AmerisourceBergen
7.4.1 AmerisourceBergen Profile
7.4.2 AmerisourceBergen Main Business
7.4.3 AmerisourceBergen Biopharmaceutical Cold Chain Transport Products, Services and Solutions
7.4.4 AmerisourceBergen Biopharmaceutical Cold Chain Transport Revenue (US$ Million) & (2019-2024)
7.4.5 AmerisourceBergen Recent Developments
7.5 UPS (Marken)
7.5.1 UPS (Marken) Profile
7.5.2 UPS (Marken) Main Business
7.5.3 UPS (Marken) Biopharmaceutical Cold Chain Transport Products, Services and Solutions
7.5.4 UPS (Marken) Biopharmaceutical Cold Chain Transport Revenue (US$ Million) & (2019-2024)
7.5.5 UPS (Marken) Recent Developments
7.6 DB Schenker
7.6.1 DB Schenker Profile
7.6.2 DB Schenker Main Business
7.6.3 DB Schenker Biopharmaceutical Cold Chain Transport Products, Services and Solutions
7.6.4 DB Schenker Biopharmaceutical Cold Chain Transport Revenue (US$ Million) & (2019-2024)
7.6.5 DB Schenker Recent Developments
7.7 XPO Logistics
7.7.1 XPO Logistics Profile
7.7.2 XPO Logistics Main Business
7.7.3 XPO Logistics Biopharmaceutical Cold Chain Transport Products, Services and Solutions
7.7.4 XPO Logistics Biopharmaceutical Cold Chain Transport Revenue (US$ Million) & (2019-2024)
7.7.5 XPO Logistics Recent Developments
7.8 Panalpina
7.8.1 Panalpina Profile
7.8.2 Panalpina Main Business
7.8.3 Panalpina Biopharmaceutical Cold Chain Transport Products, Services and Solutions
7.8.4 Panalpina Biopharmaceutical Cold Chain Transport Revenue (US$ Million) & (2019-2024)
7.8.5 Panalpina Recent Developments
7.9 Nippon Express
7.9.1 Nippon Express Profile
7.9.2 Nippon Express Main Business
7.9.3 Nippon Express Biopharmaceutical Cold Chain Transport Products, Services and Solutions
7.9.4 Nippon Express Biopharmaceutical Cold Chain Transport Revenue (US$ Million) & (2019-2024)
7.9.5 Nippon Express Recent Developments
7.10 GEODIS
7.10.1 GEODIS Profile
7.10.2 GEODIS Main Business
7.10.3 GEODIS Biopharmaceutical Cold Chain Transport Products, Services and Solutions
7.10.4 GEODIS Biopharmaceutical Cold Chain Transport Revenue (US$ Million) & (2019-2024)
7.10.5 GEODIS Recent Developments
7.11 VersaCold
7.11.1 VersaCold Profile
7.11.2 VersaCold Main Business
7.11.3 VersaCold Biopharmaceutical Cold Chain Transport Products, Services and Solutions
7.11.4 VersaCold Biopharmaceutical Cold Chain Transport Revenue (US$ Million) & (2019-2024)
7.11.5 VersaCold Recent Developments
7.12 Agility
7.12.1 Agility Profile
7.12.2 Agility Main Business
7.12.3 Agility Biopharmaceutical Cold Chain Transport Products, Services and Solutions
7.12.4 Agility Biopharmaceutical Cold Chain Transport Revenue (US$ Million) & (2019-2024)
7.12.5 Agility Recent Developments
7.13 DSV
7.13.1 DSV Profile
7.13.2 DSV Main Business
7.13.3 DSV Biopharmaceutical Cold Chain Transport Products, Services and Solutions
7.13.4 DSV Biopharmaceutical Cold Chain Transport Revenue (US$ Million) & (2019-2024)
7.13.5 DSV Recent Developments
7.14 Sinotrans
7.14.1 Sinotrans Profile
7.14.2 Sinotrans Main Business
7.14.3 Sinotrans Biopharmaceutical Cold Chain Transport Products, Services and Solutions
7.14.4 Sinotrans Biopharmaceutical Cold Chain Transport Revenue (US$ Million) & (2019-2024)
7.14.5 Sinotrans Recent Developments
7.15 Kerry Logistics
7.15.1 Kerry Logistics Profile
7.15.2 Kerry Logistics Main Business
7.15.3 Kerry Logistics Biopharmaceutical Cold Chain Transport Products, Services and Solutions
7.15.4 Kerry Logistics Biopharmaceutical Cold Chain Transport Revenue (US$ Million) & (2019-2024)
7.15.5 Kerry Logistics Recent Developments
7.16 SF Express
7.16.1 SF Express Profile
7.16.2 SF Express Main Business
7.16.3 SF Express Biopharmaceutical Cold Chain Transport Products, Services and Solutions
7.16.4 SF Express Biopharmaceutical Cold Chain Transport Revenue (US$ Million) & (2019-2024)
7.16.5 SF Express Recent Developments
7.17 CEVA
7.17.1 CEVA Profile
7.17.2 CEVA Main Business
7.17.3 CEVA Biopharmaceutical Cold Chain Transport Products, Services and Solutions
7.17.4 CEVA Biopharmaceutical Cold Chain Transport Revenue (US$ Million) & (2019-2024)
7.17.5 CEVA Recent Developments
7.18 CH Robinson
7.18.1 CH Robinson Profile
7.18.2 CH Robinson Main Business
7.18.3 CH Robinson Biopharmaceutical Cold Chain Transport Products, Services and Solutions
7.18.4 CH Robinson Biopharmaceutical Cold Chain Transport Revenue (US$ Million) & (2019-2024)
7.18.5 CH Robinson Recent Developments
7.19 Air Canada Cargo
7.19.1 Air Canada Cargo Profile
7.19.2 Air Canada Cargo Main Business
7.19.3 Air Canada Cargo Biopharmaceutical Cold Chain Transport Products, Services and Solutions
7.19.4 Air Canada Cargo Biopharmaceutical Cold Chain Transport Revenue (US$ Million) & (2019-2024)
7.19.5 Air Canada Cargo Recent Developments
8 Industry Chain Analysis
8.1 Biopharmaceutical Cold Chain Transport Industrial Chain
8.2 Biopharmaceutical Cold Chain Transport Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Biopharmaceutical Cold Chain Transport Sales Model
8.5.2 Sales Channel
8.5.3 Biopharmaceutical Cold Chain Transport Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Biopharmaceutical Cold Chain Transport Market Trends
    Table 2. Biopharmaceutical Cold Chain Transport Market Drivers & Opportunity
    Table 3. Biopharmaceutical Cold Chain Transport Market Challenges
    Table 4. Biopharmaceutical Cold Chain Transport Market Restraints
    Table 5. Global Biopharmaceutical Cold Chain Transport Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Biopharmaceutical Cold Chain Transport Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Biopharmaceutical Cold Chain Transport Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Biopharmaceutical Cold Chain Transport Product Type
    Table 9. Key Companies Time to Begin Mass Production of Biopharmaceutical Cold Chain Transport
    Table 10. Global Biopharmaceutical Cold Chain Transport Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical Cold Chain Transport as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Biopharmaceutical Cold Chain Transport Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Biopharmaceutical Cold Chain Transport Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Biopharmaceutical Cold Chain Transport Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Biopharmaceutical Cold Chain Transport Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Biopharmaceutical Cold Chain Transport Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Biopharmaceutical Cold Chain Transport Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Biopharmaceutical Cold Chain Transport Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Biopharmaceutical Cold Chain Transport Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Biopharmaceutical Cold Chain Transport Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Biopharmaceutical Cold Chain Transport Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Biopharmaceutical Cold Chain Transport Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Biopharmaceutical Cold Chain Transport Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Biopharmaceutical Cold Chain Transport Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Biopharmaceutical Cold Chain Transport Sales Value by Region (2019-2024) & (%)
    Table 27. Global Biopharmaceutical Cold Chain Transport Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Biopharmaceutical Cold Chain Transport Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Biopharmaceutical Cold Chain Transport Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Biopharmaceutical Cold Chain Transport Sales Value, (2025-2030) & (US$ Million)
    Table 31. Deutsche Post DHL Basic Information List
    Table 32. Deutsche Post DHL Description and Business Overview
    Table 33. Deutsche Post DHL Biopharmaceutical Cold Chain Transport Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Biopharmaceutical Cold Chain Transport Business of Deutsche Post DHL (2019-2024)
    Table 35. Deutsche Post DHL Recent Developments
    Table 36. Kuehne + Nagel Basic Information List
    Table 37. Kuehne + Nagel Description and Business Overview
    Table 38. Kuehne + Nagel Biopharmaceutical Cold Chain Transport Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Biopharmaceutical Cold Chain Transport Business of Kuehne + Nagel (2019-2024)
    Table 40. Kuehne + Nagel Recent Developments
    Table 41. FedEx Basic Information List
    Table 42. FedEx Description and Business Overview
    Table 43. FedEx Biopharmaceutical Cold Chain Transport Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Biopharmaceutical Cold Chain Transport Business of FedEx (2019-2024)
    Table 45. FedEx Recent Developments
    Table 46. AmerisourceBergen Basic Information List
    Table 47. AmerisourceBergen Description and Business Overview
    Table 48. AmerisourceBergen Biopharmaceutical Cold Chain Transport Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Biopharmaceutical Cold Chain Transport Business of AmerisourceBergen (2019-2024)
    Table 50. AmerisourceBergen Recent Developments
    Table 51. UPS (Marken) Basic Information List
    Table 52. UPS (Marken) Description and Business Overview
    Table 53. UPS (Marken) Biopharmaceutical Cold Chain Transport Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Biopharmaceutical Cold Chain Transport Business of UPS (Marken) (2019-2024)
    Table 55. UPS (Marken) Recent Developments
    Table 56. DB Schenker Basic Information List
    Table 57. DB Schenker Description and Business Overview
    Table 58. DB Schenker Biopharmaceutical Cold Chain Transport Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Biopharmaceutical Cold Chain Transport Business of DB Schenker (2019-2024)
    Table 60. DB Schenker Recent Developments
    Table 61. XPO Logistics Basic Information List
    Table 62. XPO Logistics Description and Business Overview
    Table 63. XPO Logistics Biopharmaceutical Cold Chain Transport Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Biopharmaceutical Cold Chain Transport Business of XPO Logistics (2019-2024)
    Table 65. XPO Logistics Recent Developments
    Table 66. Panalpina Basic Information List
    Table 67. Panalpina Description and Business Overview
    Table 68. Panalpina Biopharmaceutical Cold Chain Transport Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Biopharmaceutical Cold Chain Transport Business of Panalpina (2019-2024)
    Table 70. Panalpina Recent Developments
    Table 71. Nippon Express Basic Information List
    Table 72. Nippon Express Description and Business Overview
    Table 73. Nippon Express Biopharmaceutical Cold Chain Transport Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Biopharmaceutical Cold Chain Transport Business of Nippon Express (2019-2024)
    Table 75. Nippon Express Recent Developments
    Table 76. GEODIS Basic Information List
    Table 77. GEODIS Description and Business Overview
    Table 78. GEODIS Biopharmaceutical Cold Chain Transport Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Biopharmaceutical Cold Chain Transport Business of GEODIS (2019-2024)
    Table 80. GEODIS Recent Developments
    Table 81. VersaCold Basic Information List
    Table 82. VersaCold Description and Business Overview
    Table 83. VersaCold Biopharmaceutical Cold Chain Transport Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Biopharmaceutical Cold Chain Transport Business of VersaCold (2019-2024)
    Table 85. VersaCold Recent Developments
    Table 86. Agility Basic Information List
    Table 87. Agility Description and Business Overview
    Table 88. Agility Biopharmaceutical Cold Chain Transport Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Biopharmaceutical Cold Chain Transport Business of Agility (2019-2024)
    Table 90. Agility Recent Developments
    Table 91. DSV Basic Information List
    Table 92. DSV Description and Business Overview
    Table 93. DSV Biopharmaceutical Cold Chain Transport Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Biopharmaceutical Cold Chain Transport Business of DSV (2019-2024)
    Table 95. DSV Recent Developments
    Table 96. Sinotrans Basic Information List
    Table 97. Sinotrans Description and Business Overview
    Table 98. Sinotrans Biopharmaceutical Cold Chain Transport Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Biopharmaceutical Cold Chain Transport Business of Sinotrans (2019-2024)
    Table 100. Sinotrans Recent Developments
    Table 101. Kerry Logistics Basic Information List
    Table 102. Kerry Logistics Description and Business Overview
    Table 103. Kerry Logistics Biopharmaceutical Cold Chain Transport Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Biopharmaceutical Cold Chain Transport Business of Kerry Logistics (2019-2024)
    Table 105. Kerry Logistics Recent Developments
    Table 106. SF Express Basic Information List
    Table 107. SF Express Description and Business Overview
    Table 108. SF Express Biopharmaceutical Cold Chain Transport Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Biopharmaceutical Cold Chain Transport Business of SF Express (2019-2024)
    Table 110. SF Express Recent Developments
    Table 111. CEVA Basic Information List
    Table 112. CEVA Description and Business Overview
    Table 113. CEVA Biopharmaceutical Cold Chain Transport Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Biopharmaceutical Cold Chain Transport Business of CEVA (2019-2024)
    Table 115. CEVA Recent Developments
    Table 116. CH Robinson Basic Information List
    Table 117. CH Robinson Description and Business Overview
    Table 118. CH Robinson Biopharmaceutical Cold Chain Transport Products, Services and Solutions
    Table 119. Revenue (US$ Million) in Biopharmaceutical Cold Chain Transport Business of CH Robinson (2019-2024)
    Table 120. CH Robinson Recent Developments
    Table 121. Air Canada Cargo Basic Information List
    Table 122. Air Canada Cargo Description and Business Overview
    Table 123. Air Canada Cargo Biopharmaceutical Cold Chain Transport Products, Services and Solutions
    Table 124. Revenue (US$ Million) in Biopharmaceutical Cold Chain Transport Business of Air Canada Cargo (2019-2024)
    Table 125. Air Canada Cargo Recent Developments
    Table 126. Key Raw Materials Lists
    Table 127. Raw Materials Key Suppliers Lists
    Table 128. Biopharmaceutical Cold Chain Transport Downstream Customers
    Table 129. Biopharmaceutical Cold Chain Transport Distributors List
    Table 130. Research Programs/Design for This Report
    Table 131. Key Data Information from Secondary Sources
    Table 132. Key Data Information from Primary Sources
    Table 133. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Biopharmaceutical Cold Chain Transport Product Picture
    Figure 2. Global Biopharmaceutical Cold Chain Transport Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Biopharmaceutical Cold Chain Transport Sales Value (2019-2030) & (US$ Million)
    Figure 4. Biopharmaceutical Cold Chain Transport Report Years Considered
    Figure 5. Global Biopharmaceutical Cold Chain Transport Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Biopharmaceutical Cold Chain Transport Revenue in 2023
    Figure 7. Biopharmaceutical Cold Chain Transport Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Ground Shipping Picture
    Figure 9. Sea Shipping Picture
    Figure 10. Air Shipping Picture
    Figure 11. Global Biopharmaceutical Cold Chain Transport Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global Biopharmaceutical Cold Chain Transport Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of Blood Products
    Figure 14. Product Picture of Vaccines
    Figure 15. Product Picture of Others
    Figure 16. Global Biopharmaceutical Cold Chain Transport Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Biopharmaceutical Cold Chain Transport Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America Biopharmaceutical Cold Chain Transport Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America Biopharmaceutical Cold Chain Transport Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe Biopharmaceutical Cold Chain Transport Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe Biopharmaceutical Cold Chain Transport Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific Biopharmaceutical Cold Chain Transport Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific Biopharmaceutical Cold Chain Transport Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America Biopharmaceutical Cold Chain Transport Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America Biopharmaceutical Cold Chain Transport Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa Biopharmaceutical Cold Chain Transport Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa Biopharmaceutical Cold Chain Transport Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions Biopharmaceutical Cold Chain Transport Sales Value (%), (2019-2030)
    Figure 29. United States Biopharmaceutical Cold Chain Transport Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States Biopharmaceutical Cold Chain Transport Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States Biopharmaceutical Cold Chain Transport Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe Biopharmaceutical Cold Chain Transport Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe Biopharmaceutical Cold Chain Transport Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe Biopharmaceutical Cold Chain Transport Sales Value by Application (%), 2023 VS 2030
    Figure 35. China Biopharmaceutical Cold Chain Transport Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China Biopharmaceutical Cold Chain Transport Sales Value by Type (%), 2023 VS 2030
    Figure 37. China Biopharmaceutical Cold Chain Transport Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan Biopharmaceutical Cold Chain Transport Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan Biopharmaceutical Cold Chain Transport Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan Biopharmaceutical Cold Chain Transport Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea Biopharmaceutical Cold Chain Transport Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea Biopharmaceutical Cold Chain Transport Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea Biopharmaceutical Cold Chain Transport Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia Biopharmaceutical Cold Chain Transport Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Biopharmaceutical Cold Chain Transport Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia Biopharmaceutical Cold Chain Transport Sales Value by Application (%), 2023 VS 2030
    Figure 47. India Biopharmaceutical Cold Chain Transport Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India Biopharmaceutical Cold Chain Transport Sales Value by Type (%), 2023 VS 2030
    Figure 49. India Biopharmaceutical Cold Chain Transport Sales Value by Application (%), 2023 VS 2030
    Figure 50. Biopharmaceutical Cold Chain Transport Industrial Chain
    Figure 51. Biopharmaceutical Cold Chain Transport Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart